61 Insights into interferons (IFN)-myeloid cell crosstalk: an analysis of E3611 testing ipilimumab alone or in combination with IFN-α in advanced melanoma
Ahmad A. Tarhini(UPMC Hillman Cancer Center), John M. Kirkwood(UPMC Hillman Cancer Center), Paulo C. Rodrı́guez(Moffitt Cancer Center), James Santos, Mark R. Albertini(University of Wisconsin–Madison), Jo Bender(Navidea Biopharmaceuticals (United States)), Phu Truong(Cancer Center of Kansas), Sandra J. Lee(Dana-Farber Cancer Institute), Jaspreet Kaur(Navidea Biopharmaceuticals (United States)), Islam Eljilany(Moffitt Cancer Center), Arun Nagarajan(Cleveland Clinic Florida), Stuart J. Wong(Medical College of Wisconsin), Richard Van Krieken(Lineage Cell Therapeutics (United States)), Mark Taylor(Alkermes (United States)), Jennifer Bordeaux(Lineage Cell Therapeutics (United States))
Cited by 0
Related Papers
Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses
|Cancer Research|2004|1.2k
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
|Nature Reviews Clinical Oncology|2016|1.1k
Antibody validation
|BioTechniques|2010|601
Linear Motif Atlas for Phosphorylation-Dependent Signaling
|Science Signaling|2008|465